ETON News and Press, Eton Pharmaceutcials Inc. From 11/02/22

DEER PARK, Ill., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report third quarter 2022 financial results on Thursday, No...

SWK Holdings Provides Portfolio Update Highlighting Recent Achievements PR Newswire Third Quarter 2022 Financial Results to be Announced in Early November DALLAS , Oct. 18, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the...

DEER PARK, Ill., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that Sean Brynjelsen, Ch...

RALEIGH, NC / ACCESSWIRE / September 27, 2022 / The 2 nd Annual MicroCap Rodeo Conference is going on the road and will take place at the Swissotel in Chicago on October 12 th - 13th, 2022, where 60+ SmallCap, MicroCap and NanoCap public companies will be presenting to a global investor au...

-- Expected to be accretive to 2023 earnings -- DEER PARK, Ill., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for ra...

DEER PARK, Ill., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that Sean Brynjelsen, Ch...

The shares of the commercial-stage biopharma Eton Pharmaceuticals ( NASDAQ: ETON ) dropped on Tuesday to reach a 52-week low after a legal setback in its plans to bring a generic version of cysteine hydrochloride injection. In an Aug. 08 ruling, a Delaware District Court j...

Today, we revisit fast evolving biopharma name Eton Pharmaceuticals for the first time since October of last year. Since then, the company has launched several key products and made a key divestiture. What is ahead for this intriguing small cap concern? An investment analysis...

Eton Pharmaceuticals, Inc. (ETON) Q2 2022 Earnings Conference Call August 11, 2022 16:30 ET Company Participants David Krempa - Senior Vice President of Business Development & Investor Relations Sean Brynjelsen - President & Chief Executive Officer James ...

Eton Pharmaceuticals press release ( NASDAQ: ETON ): Q2 GAAP EPS of -$0.06 misses by $0.09 . Revenue of $7.4M (+141.0% Y/Y) misses by $0.36M . For further details see: Eton Pharmaceuticals GAAP EPS of -$0.06 misses by $0.09, revenue of $7.4M misses by $0....